CAMERA2
2020
Combination Antibiotic Therapy for MRSA Bacteraemia
In 352 patients with MRSA bacteraemia, standard therapy plus an anti-staphylococcal β-lactam did not improve a composite of mortality, persistent bacteraemia and relapse versus standard therapy alone and acute kidney injury increased.
Result
- Absolute difference
- 4 points
absolute difference-4.295% CI -14.3 to 6.0
The absolute difference is derived from the event rates.
Also reported: Acute kidney injury 23% vs 6%.
- Subtopic
- MRSA bacteraemia
- Design
- Open-label RCT, stopped early for safety
- Relevance
- Important: one of several pillars.
- Source
- Tong SYC, et al. JAMA. 2020;323(6):527-537.doi 10.1001/jama.2020.0103
Discussion & critique
Routine upfront β-lactam combination is harmful in MRSA bacteraemia without benefit; vancomycin or daptomycin monotherapy remains standard.